Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 4,614 | 351 | 2,532 | 127 | 992 |
| Gross Profit | 4,614 | 351 | 2,532 | 127 | 992 |
| Operating Expenses | 6,767 | 9,183 | 10,287 | 9,553 | 6,585 |
| Operating Income | -2,153 | -8,832 | -7,755 | -9,426 | -5,593 |
| Interest Expense | 655 | 530 | 551 | 561 | 551 |
| Other Income | -23,538 | -23,925 | -484 | 4,383 | 1,178 |
| Pre-tax Income | -26,346 | -33,287 | -8,790 | -5,604 | -4,966 |
| Income Tax | 51 | N/A | 50 | 1 | N/A |
| Net Income Continuous | -26,397 | -33,287 | -8,840 | -5,605 | -4,966 |
| Net Income | $-26,397 | $-33,287 | $-8,840 | $-5,605 | $-4,966 |
| EPS Basic Total Ops | -2.20 | -3.00 | -1.20 | -0.60 | -0.70 |
| EPS Basic Continuous Ops | -2.24 | -3.01 | -1.16 | -0.62 | -0.65 |
| EPS Diluted Total Ops | -2.20 | -3.00 | -1.20 | -0.60 | -0.70 |
| EPS Diluted Continuous Ops | -2.24 | -3.01 | -1.16 | -0.62 | -0.65 |
| EBITDA(a) | $-2,129 | $-8,817 | $-7,758 | $-9,395 | $-5,600 |